Search

Your search keyword '"Blaauboer, Bas"' showing total 604 results

Search Constraints

Start Over You searched for: Author "Blaauboer, Bas" Remove constraint Author: "Blaauboer, Bas"
604 results on '"Blaauboer, Bas"'

Search Results

1. Improving the quality of toxicology and environmental health systematic reviews: What journal editors can do.

2. The EU chemicals strategy for sustainability: in support of the BfR position

3. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity: how to evaluate the risk of the S-EDCs?

4. A strategy for systemic toxicity assessment based on non-animal approaches: The Cosmetics Europe Long Range Science Strategy programme

5. Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing

10. Contributors

24. Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress

27. New approach methodologies (NAMs) for human-relevant biokinetics predictions

31. Critique of the “Comment” etitled “Pyrethroid exposure: Not so harmless after all” by Demeneix et al. (2020) published in the lancet diabetes endocrinology

34. Corrigendum to “Critique of the “Comment” etitled “Pyrethroid exposure: not so harmless after all” by Demeneix et al. (2020) published in the lancet diabetes endocrinology”

35. Critique of the 'Comment' etitled 'Pyrethroid exposure: Not so harmless after all' by Demeneix et al. (2020) published in the lancet diabetes endocrinology

36. The EU chemicals strategy for sustainability: in support of the BfR position

39. New approach methodologies (NAMs) for human-relevant biokinetics predictions: Meeting the paradigm shift in toxicology towards an animal-free chemical risk assessment

40. New approach methodologies (NAMs) for human-relevant biokinetics predictions: Meeting the paradigm shift in toxicology towards an animal-free chemical risk assessment

41. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?

42. Open letter to the European commission: scientifically unfounded precaution drives European commission’s recommendations on EDC regulation, while defying common sense, well-established science, and risk assessment principles

43. Editorial

44. Scientifically unfounded precaution drives European Commissionʼs recommendations on EDC regulation, while defying common sense, well-established science and risk assessment principles

47. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?

Catalog

Books, media, physical & digital resources